Dick Menzies

14PUBLICATIONS
34CO-AUTHORS
Immunogenetics (incl. genetic immunology)Epidemiological methodsDisease surveillancePreventative health careHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 25, 2026
Diagnostic Performance of New Commercial Interferon-Gamma Release Assays for Mycobacterium tuberculosis Infection: An Updated Systematic Review and Meta-analysis.

Lika Apriani, Harsimren Sidhu, Alexei Korobitsyn

|Jan 27, 2026
Population Pharmacokinetic Modeling of Standard- and High-Dose Rifampicin for Tuberculosis Preventive Therapy in the 2R2 Randomized Controlled Trial.

Fajri Gafar, Elin M Svensson, Vycke Yunivita

|Sep 22, 2025
Costs of 4 Months of Rifampin Versus 2 Months of Double-dose Rifampin for Tuberculosis Infection: Post-Hoc Analysis of a Phase 2b Randomized Trial.

Kamila Romanowski, Yen Pham Ngoc, Leila Barss

|Jul 28, 2025
Rapid molecular testing or chest X-ray or tuberculin skin testing for household contact assessment of tuberculosis infection: A cluster-randomized trial.

Menonli Adjobimey, Anete Trajman, Mayara Lisboa Bastos

|Jan 10, 2025
Safety of Triple-Dose Rifampin in Tuberculosis Treatment: A Systematic Review and Meta-Analysis.

Omri A Arbiv, Thomas Holmes, Marie JeongMin Kim

|Feb 02, 2023
High dose rifampin for 2 months vs standard dose rifampin for 4 months, to treat TB infection: Protocol of a 3-arm randomized trial (2R2).

Federica Fregonese, Lika Apriani, Leila Barss

Pageof 3

Frequent Collaborators

7 joint publications

Jonathon R Campbell

5 joint publications

Olivia Oxlade

3 joint publications

Mayara Lisboa Bastos

3 joint publications

James Johnston